How AI and a Global Pandemic led to a $175M Investment: Ardis Kadiu’s Element451 Story
JONES DAY TALKS®: Real Assets Roundup Episode 4: Legal and Energy Challenges of Powering Data Centers
Key Discovery Points: A Gentle Distinction for Agentic AI
Work This Way: A Labor & Employment Law Podcast | How Employers Can Protect Intellectual Property with Bryan Baysinger of Maynard Nexsen
False Claims Act Insights - An FCA Perspective on Artificial Intelligence in the Healthcare Industry
(Podcast) The Briefing: Publicity Rights and the Law – Using Real People in Your Work
AI Today in 5: August 22, 2025, The Angst Episode
The Briefing: Publicity Rights and the Law – Using Real People in Your Work
IP Goes Pop! S6 Ep #3 The (Copy)Right Tool for the Job- The Copyright Tool Kit
Compliance Tip of the Day: Using AI to Embed Your Compliance Program
PODCAST: Williams Mullen's Trending Now: An IP Podcast - Who Owns AI Innovation? IP in the Age of Artificial Intelligence
Operationalizing Trust at Scale: Evolving Compliance: Neta Meidav on the Diligent Acquisition and AI Integration
AI Today in 5: August 21, 2025, The AI Psychosis Episode
Compliance Tip of the Day: Trust and Verify
Great Woman in Compliance: Building Strategic and Effective Risk Assessments
Compliance into the Weeds: The Dark Side of AI in Employee Training
Compliance Tip of the Day: AI Assistant for Compliance
AI Today in 5: August 19, 2025. The AI and Compliance Episode
Innovation in Compliance: Gaurav Kapoor on Risk Management and the Role of AI in GRC
Daily Compliance News: August 19, 2025, The AI Winter Edition
If you’re raising early-stage capital, the outlook appears strong, but for late-stage companies, the bar is higher than ever. In partnership with Aumni, a J.P. Morgan company, we’re pleased to share the Q2 2025 edition of the...more
At New York Tech Week 2025, cybersecurity took the spotlight. Fenwick partner Jon Lenzner sat down with Bryan Vorndran—former assistant director of the FBI’s Cyber Division—to unpack what early-stage companies, investors, and...more
As we head into the second half of 2025, the prospects for innovation in robotics and artificial intelligence (AI) seem limitless. It is difficult to find an industry that hasn’t touted the potential for robotics and AI to...more
From lab to commercialization: Navigate the evolving risks of life science companies - Life science companies face rapidly evolving risks—from navigating insurance needs during early funding stages to understanding...more
As we kick off 2025, it's worth reflecting on the forces that shaped digital health in 2024. From early-stage innovation capturing investor attention to mega funds like a16z and General Catalyst driving dealmaking, the year...more
When developing an internal company artificial intelligence policy, there are three main things that a policy should do. One, it should explain to employees what types of tools they can use and what types of accounts they...more
01 A conversation with Evercore on the market outlook 02 Will there be an alternative path to public? 03 What’s ahead for tech and life sciences IPOs? 04 The Download Quiz: Venture Capital Trends / 01A CONVERSATION WITH...more
This update is part of our EU AI Act Series. Learn more about the EU AI Act here. Like other companies, startups that develop, use or commercialize AI systems or general-purpose AI models (GPAIMs) that people in the EU use...more
Founders and folks that are really pushing the envelope in this space need to be careful with how they describe their tools when it comes to due diligence. We're working from an environment where most people are just focused...more
Wilson Sonsini’s inaugural Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI...more
In the rapidly evolving landscape of AI, the valuation and viability of AI companies are extensively tied to their intellectual property assets. For AI companies, safeguarding these assets is not just about legal...more
Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies, including early and late-stage venture financing, partnering...more
As is the case with most emerging technologies, developments in artificial intelligence (AI) are quickly outpacing regulations, and with this comes a variety of important legal considerations. While there has been a push for...more
Welcome to the March edition of Blakes upRound, a regular publication from the Blakes Emerging Companies & Venture Capital (EC&VC) group that highlights legal developments relevant to venture investors and emerging companies...more
Introduction - Welcome to the second issue of The Scramble, presented by Wilson Sonsini’s Electronic Gaming Group. Wilson Sonsini has advised hundreds of clients throughout the gaming sector. The Scramble is an annual...more
Food Venture Financing Trends - Amara, an organic baby food brand, announced that it raised $20 million in its Series B financing. Liquid Death, a fast-growing non-alcoholic brand, announced that it has raised $67...more
2023 was a pivotal year for the emerging companies, creating new categories of winners and losers across the board. Emerging companies incorporating artificial intelligence or that have clear line of sight to positive cash...more
In this latest issue of The Entrepreneurs Report, we've compiled a range of data on venture financing transactions and convertible note financings in which the firm was involved in Q3 2023, with the objective of identifying...more
Morrison Foerster is pleased to share with our clients and friends the results of our 2023 Tech M&A Survey, published in conjunction with Mergermarket. Mergermarket surveyed 300 dealmakers from around the world in order to...more
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the...more
Some interesting links we found across the web this week: While Startup-to-Startup Acquisitions Remain Strong, Public Companies Pull Back - This year has seen public companies pulling back on their acquisitions of...more
At the Life Sciences Dealmaking Symposium and Investment Forum, seasoned dealmakers, investors industry executives and technical experts will join McDermott's leading transactional, venture financing and private equity...more